Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for Q8IWE4

Entry ID Method Resolution Chain Position Source
4GBA X-ray 240 A A/B 86-304 PDB
AF-Q8IWE4-F1 Predicted AlphaFoldDB

184 variants for Q8IWE4

Variant ID(s) Position Change Description Diseaes Association Provenance
TCGA novel 1 M>? Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
VAR_072689 2 G>S a cancer; unknown pathological significance [UniProt] No UniProt
CA395015854
rs1261700256
3 Q>R No ClinGen
gnomAD
CA7945332
rs760147404
5 V>I No ClinGen
ExAC
gnomAD
CA395015832
rs1340653940
6 T>I No ClinGen
gnomAD
CA395015819
rs1225245805
8 C>Y No ClinGen
gnomAD
rs1385099458
CA395015811
9 K>R No ClinGen
gnomAD
CA395015783
rs774666903
13 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs774666903
CA7945331
13 S>W No ClinGen
ExAC
gnomAD
CA7945329
rs763189938
15 L>V No ClinGen
ExAC
gnomAD
TCGA novel 19 N>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs770179050
CA7945327
22 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA7945326
rs549170536
22 R>H No ClinGen
1000Genomes
ExAC
gnomAD
rs1355144583
CA395015720
23 E>G No ClinGen
TOPMed
CA395015714
rs1386584391
24 P>S No ClinGen
gnomAD
rs1163787576
COSM968181
CA395015678
29 H>Y Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs1443602562
CA395015671
30 S>G No ClinGen
gnomAD
rs1184418335
CA395015654
32 R>K No ClinGen
gnomAD
CA7945324
rs7187522
32 R>W No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA395015650
rs1458173506
33 G>R No ClinGen
TOPMed
rs1177907045
CA395015646
33 G>V No ClinGen
TOPMed
CA395015641
rs1188578747
34 A>G No ClinGen
TOPMed
rs369289640
CA7945321
34 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 34 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1361627621
CA395015630
36 H>R No ClinGen
gnomAD
CA7945319
rs374769393
37 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA395015624
rs1245399298
COSM1203177
37 R>H large_intestine [Cosmic] No ClinGen
cosmic curated
gnomAD
CA7945315
rs754383342
41 V>A No ClinGen
ExAC
TOPMed
gnomAD
rs754383342
CA395015595
41 V>E No ClinGen
ExAC
TOPMed
gnomAD
CA7945316
rs767028379
41 V>L No ClinGen
ExAC
gnomAD
CA7945314
rs752142562
42 P>L No ClinGen
ExAC
gnomAD
rs766750785
CA7945313
43 P>L No ClinGen
ExAC
gnomAD
CA7945312
rs763483895
44 C>R No ClinGen
ExAC
gnomAD
CA7945311
rs371819424
47 P>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs371819424
CA7945310
47 P>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs149292226
CA7945308
50 D>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA395015542
rs1341340122
50 D>V No ClinGen
gnomAD
rs201398772
CA7945306
51 I>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
COSM968180
CA7945304
rs770815934
53 V>I lung Variant assessed as Somatic; 0.0 impact. endometrium [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA7945302
rs777603187
55 G>R No ClinGen
ExAC
gnomAD
CA395015501
rs1270309613
57 K>Q No ClinGen
gnomAD
rs755845816
CA7945301
59 A>S No ClinGen
ExAC
gnomAD
rs1596627979
CA395015479
60 E>G No ClinGen
Ensembl
CA7945299
rs150849224
60 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1596627978
CA395015475
61 A>P No ClinGen
Ensembl
CA395015446
rs1224566273
65 A>D No ClinGen
gnomAD
CA395015444
rs1224566273
65 A>V No ClinGen
gnomAD
CA395015415
rs754541715
70 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs200201954
CA7945297
70 T>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA7945298
rs754541715
70 T>S No ClinGen
ExAC
TOPMed
gnomAD
rs758883322
CA7945295
71 S>F No ClinGen
ExAC
TOPMed
gnomAD
rs750898376
CA7945294
72 S>L No ClinGen
ExAC
TOPMed
gnomAD
CA395015395
rs1347633456
74 D>H No ClinGen
gnomAD
rs1031088486
CA279341199
77 R>G No ClinGen
TOPMed
CA395015353
rs1308959527
80 K>R No ClinGen
TOPMed
gnomAD
rs1168345295
CA395015344
81 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs764271471
CA7945290
84 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs760918785
CA395015314
85 E>D No ClinGen
ExAC
TOPMed
gnomAD
rs1430526649
CA395015300
88 L>V No ClinGen
gnomAD
rs775501439
CA7945288
89 Q>K No ClinGen
ExAC
rs772180031
CA7945287
89 Q>P No ClinGen
ExAC
TOPMed
gnomAD
CA7945286
rs762892022
90 R>I No ClinGen
ExAC
gnomAD
CA7945285
rs138789031
90 R>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 90 R>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1379654649
CA395015262
93 E>D No ClinGen
TOPMed
gnomAD
rs747893830
CA7945283
96 R>G No ClinGen
ExAC
gnomAD
CA7945282
rs145000131
96 R>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA7945281
rs768236347
97 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA7945280
rs368022474
97 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA279341099
rs938518202
98 Y>C No ClinGen
TOPMed
rs529534017
CA7945279
99 K>R No ClinGen
1000Genomes
ExAC
gnomAD
rs141394610
CA7945277
102 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs373669655
CA7945278
102 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 105 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 108 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1318128909
CA395015121
111 M>L No ClinGen
gnomAD
rs757815463
CA7945275
112 E>A No ClinGen
ExAC
gnomAD
TCGA novel 112 E>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
COSM182803
CA279341066
rs200217368
113 R>C large_intestine [Cosmic] No ClinGen
cosmic curated
gnomAD
rs200217368
CA395015090
113 R>G No ClinGen
gnomAD
rs754293777
CA7945274
113 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA7945273
rs764516441
114 F>I No ClinGen
ExAC
gnomAD
CA7945272
rs760866653
116 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA7945271
rs752906928
119 C>S No ClinGen
ExAC
gnomAD
CA395014969
rs1427292595
121 D>E No ClinGen
TOPMed
CA395014974
rs1475167245
121 D>G No ClinGen
gnomAD
TCGA novel 121 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs759576387
CA395014902
126 R>P No ClinGen
ExAC
gnomAD
CA7945269
rs759576387
126 R>Q No ClinGen
ExAC
gnomAD
rs1243493536
CA395014897
127 V>M No ClinGen
gnomAD
rs776344865
CA7945265
131 A>V No ClinGen
ExAC
gnomAD
rs768438103
CA395014816
133 K>R No ClinGen
ExAC
TOPMed
gnomAD
CA7945264
rs768438103
133 K>T No ClinGen
ExAC
TOPMed
gnomAD
rs1340860611
CA395014770
136 A>P No ClinGen
gnomAD
CA395014761
rs746642001
137 A>S No ClinGen
ExAC
TOPMed
gnomAD
CA7945263
rs746642001
137 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs779713076
CA7945262
138 T>A No ClinGen
ExAC
gnomAD
CA7945261
rs771728742
138 T>S No ClinGen
ExAC
gnomAD
CA7945260
rs745419737
141 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs1299200520
CA395013859
146 E>K No ClinGen
gnomAD
rs77432343
CA279340104
148 F>L No ClinGen
Ensembl
rs1453586218
CA395013813
149 D>N No ClinGen
TOPMed
rs776561494
CA7945247
153 A>T No ClinGen
ExAC
gnomAD
CA395013742
rs1425453128
153 A>V No ClinGen
gnomAD
CA7945246
rs368597287
155 S>G No ClinGen
ESP
ExAC
gnomAD
CA7945245
rs199765506
155 S>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1177612698
CA395013645
160 D>G No ClinGen
gnomAD
rs202156477
CA7945241
161 G>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
gnomAD
CA395013623
rs1158122023
162 I>N No ClinGen
TOPMed
rs770510257
CA7945240
163 C>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 163 C>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs770510257
CA395013611
163 C>Y No ClinGen
ExAC
TOPMed
gnomAD
rs143835944
CA395013586
165 R>L No ClinGen
ESP
ExAC
gnomAD
CA7945239
rs143835944
165 R>Q No ClinGen
ESP
ExAC
gnomAD
CA279340069
rs199941022
167 P>S No ClinGen
1000Genomes
rs374366221
CA7945237
168 S>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA7945236
rs748599193
171 T>A No ClinGen
ExAC
gnomAD
TCGA novel 173 A>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs755262727
CA7945234
173 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs766449301
CA7945233
174 K>R No ClinGen
ExAC
TOPMed
gnomAD
CA7945232
rs766449301
174 K>T No ClinGen
ExAC
TOPMed
gnomAD
CA395013454
rs1405570212
175 Q>R No ClinGen
gnomAD
TCGA novel 179 F>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs758460882
CA7945230
181 D>A No ClinGen
ExAC
gnomAD
rs1346065603
CA395013373
181 D>E No ClinGen
gnomAD
CA279340004
rs940141790
181 D>Y No ClinGen
TOPMed
CA7945229
rs753737940
184 R>Q No ClinGen
ExAC
gnomAD
rs764140413
CA7945228
186 T>A No ClinGen
ExAC
gnomAD
rs775421022
CA7945226
192 D>Y No ClinGen
ExAC
gnomAD
TCGA novel 197 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7945225
rs767406827
197 Q>K No ClinGen
ExAC
gnomAD
rs1339285105
CA395013149
198 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA279339967
rs909974055
198 R>W No ClinGen
TOPMed
gnomAD
CA395013076
rs1265490547
204 I>T No ClinGen
gnomAD
CA7945224
rs558043046
204 I>V No ClinGen
1000Genomes
ExAC
gnomAD
CA279339942
rs148978111
211 L>P No ClinGen
ESP
rs145837764
CA7945222
215 Q>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 216 N>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1384055824
CA395012892
217 N>S No ClinGen
TOPMed
gnomAD
CA7945221
rs748783398
219 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs748783398
CA395012865
219 P>Q No ClinGen
ExAC
TOPMed
gnomAD
CA395012857
rs1456457634
220 V>I No ClinGen
TOPMed
gnomAD
TCGA novel 223 Q>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7945219
rs770377087
225 L>V No ClinGen
ExAC
gnomAD
rs149680095
CA7945218
229 T>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA7945217
rs781598413
233 S>L No ClinGen
ExAC
TOPMed
gnomAD
rs1429777844
CA395012616
CA395012617
236 K>N No ClinGen
TOPMed
gnomAD
rs1165661912
CA395012626
236 K>Q No ClinGen
TOPMed
rs1318578612
CA395012621
236 K>R No ClinGen
TOPMed
gnomAD
rs780197306
CA7945214
237 G>R No ClinGen
ExAC
gnomAD
VAR_072690 239 S>F a cancer; unknown pathological significance [UniProt] No UniProt
CA279339888
rs921234573
240 R>W No ClinGen
TOPMed
TCGA novel 242 T>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA395012486
rs1463793529
245 M>I No ClinGen
TOPMed
gnomAD
rs750556211
CA7945212
248 N>K No ClinGen
ExAC
gnomAD
CA395012432
rs1204768239
249 F>L No ClinGen
gnomAD
rs539392630
CA279339877
258 S>R No ClinGen
1000Genomes
CA395012147
rs1229622091
267 P>L No ClinGen
gnomAD
CA395012123
rs1297084435
269 L>H No ClinGen
gnomAD
CA7945210
rs756132549
269 L>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs752625678
CA7945209
270 F>S No ClinGen
ExAC
rs201159661
CA279339848
271 D>G No ClinGen
1000Genomes
CA395012082
rs1234624249
272 T>S No ClinGen
TOPMed
CA7945207
rs767425680
274 V>M No ClinGen
ExAC
TOPMed
gnomAD
rs911752536
COSM3936962
CA279339839
280 R>* oesophagus [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
CA279339838
rs142074017
280 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
NCI-TCGA
gnomAD
rs1252928312
CA395011954
281 R>G No ClinGen
TOPMed
CA395011921
rs1339819017
283 R>K No ClinGen
TOPMed
TCGA novel 284 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1170755803
CA395011888
285 G>W No ClinGen
gnomAD
TCGA novel 286 E>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7945205
rs751280783
287 G>E No ClinGen
ExAC
TOPMed
gnomAD
CA395011859
rs1249895641
287 G>R No ClinGen
TOPMed
TCGA novel 288 R>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs372534815
CA279339832
291 L>F No ClinGen
ESP
TOPMed
gnomAD
CA395011772
rs1173145534
293 S>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA395011764
rs1366434232
294 G>E No ClinGen
TOPMed
gnomAD
CA7945202
rs772847778
295 P>L No ClinGen
ExAC
gnomAD
CA279339811
rs1022048304
296 E>A No ClinGen
TOPMed
gnomAD
CA395011726
rs1442214298
297 G>V No ClinGen
gnomAD
rs1167051721
CA395011712
298 L>F No ClinGen
TOPMed
rs777080283
CA7945199
301 E>K No ClinGen
ExAC
gnomAD
CA395011629
rs1442887626
304 T>A No ClinGen
gnomAD
rs62033352
CA279339792
304 T>I No ClinGen
Ensembl

No associated diseases with Q8IWE4

1 regional properties for Q8IWE4

Type Name Position InterPro Accession
domain Potentiating neddylation domain 86 - 278 IPR005176

Functions

Description
EC Number
Subcellular Localization
  • Cell membrane
  • Cytoplasm
  • Nucleus
  • Cytoplasm, perinuclear region
  • After UVC treatment, the protein enters to the nucleus gradually (PubMed:18823379)
  • Cell membrane localization is essential for CUL3 neddylation (PubMed:19617556)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
perinuclear region of cytoplasm Cytoplasm situated near, or occurring around, the nucleus.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
ubiquitin ligase complex A protein complex that includes a ubiquitin-protein ligase and enables ubiquitin protein ligase activity. The complex also contains other proteins that may confer substrate specificity on the complex.

3 GO annotations of molecular function

Name Definition
cullin family protein binding Binding to a member of the cullin family, hydrophobic proteins that act as scaffolds for ubiquitin ligases (E3).
ubiquitin conjugating enzyme binding Binding to a ubiquitin conjugating enzyme, any of the E2 proteins.
ubiquitin-like protein binding Binding to a small conjugating protein such as ubiquitin or a ubiquitin-like protein.

11 GO annotations of biological process

Name Definition
negative regulation of cell growth Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
negative regulation of G1/S transition of mitotic cell cycle Any signalling pathway that decreases or inhibits the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the mitotic cell cycle.
negative regulation of protein neddylation Any process that stops, prevents or reduces the frequency, rate or extent of protein neddylation.
positive regulation of apoptotic process Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
positive regulation of protein neddylation Any process that activates or increases the frequency, rate or extent of protein neddylation.
positive regulation of ubiquitin-protein transferase activity Any process that activates, maintains or increases the rate of ubiquitin transferase activity.
protein neddylation Covalent attachment of the ubiquitin-like protein NEDD8 (RUB1) to another protein.
regulation of cell cycle process Any process that modulates a cellular process that is involved in the progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events.
regulation of protein neddylation Any process that modulates the frequency, rate or extent of protein neddylation.
response to gamma radiation Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gamma radiation stimulus. Gamma radiation is a form of electromagnetic radiation (EMR) or light emission of a specific frequency produced from sub-atomic particle interaction, such as electron-positron annihilation and radioactive decay. Gamma rays are generally characterized as EMR having the highest frequency and energy, and also the shortest wavelength, within the electromagnetic radiation spectrum.
response to UV-C Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a UV-C radiation stimulus. UV-C radiation (UV-C light) spans the wavelengths 100 to 280 nm.

5 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q5E9V1 DCUN1D3 DCN1-like protein 3 Bos taurus (Bovine) PR
Q8K0V2 Dcun1d3 DCN1-like protein 3 Mus musculus (Mouse) PR
Q4V8B2 Dcun1d3 DCN1-like protein 3 Rattus norvegicus (Rat) PR
Q9U3C8 dcn-1 Defective in cullin neddylation protein 1 Caenorhabditis elegans PR
A4IHK8 dcun1d3 DCN1-like protein 3 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
10 20 30 40 50 60
MGQCVTKCKN PSSTLGSKNG DREPSNKSHS RRGAGHREEQ VPPCGKPGGD ILVNGTKKAE
70 80 90 100 110 120
AATEACQLPT SSGDAGRESK SNAEESSLQR LEELFRRYKD EREDAILEEG MERFCNDLCV
130 140 150 160 170 180
DPTEFRVLLL AWKFQAATMC KFTRKEFFDG CKAISADSID GICARFPSLL TEAKQEDKFK
190 200 210 220 230 240
DLYRFTFQFG LDSEEGQRSL HREIAIALWK LVFTQNNPPV LDQWLNFLTE NPSGIKGISR
250 260 270 280 290 300
DTWNMFLNFT QVIGPDLSNY SEDEAWPSLF DTFVEWEMER RKREGEGRGA LSSGPEGLCP
EEQT